Emily B. Button

939 total citations
23 papers, 679 citations indexed

About

Emily B. Button is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Emily B. Button has authored 23 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 12 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Emily B. Button's work include Alzheimer's disease research and treatments (11 papers), Traumatic Brain Injury and Neurovascular Disturbances (5 papers) and Traumatic Brain Injury Research (4 papers). Emily B. Button is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Traumatic Brain Injury and Neurovascular Disturbances (5 papers) and Traumatic Brain Injury Research (4 papers). Emily B. Button collaborates with scholars based in Canada, Switzerland and Sweden. Emily B. Button's co-authors include Cheryl L. Wellington, Jérôme Robert, Sophie Stukas, Jianjia Fan, Wenchen Zhao, Anna Wilkinson, Wai Hang Cheng, Iva Kulić, Tara M. Caffrey and Kris M. Martens and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Psychopharmacology.

In The Last Decade

Emily B. Button

22 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily B. Button Canada 15 283 187 166 149 123 23 679
Jiunn-Tay Lee Taiwan 9 188 0.7× 259 1.4× 105 0.6× 157 1.1× 84 0.7× 11 596
Antonietta Fava Italy 16 381 1.3× 147 0.8× 152 0.9× 205 1.4× 89 0.7× 26 988
Hui‐Fu Wang China 10 260 0.9× 209 1.1× 128 0.8× 58 0.4× 109 0.9× 17 609
Massimiliano Plastino Italy 14 275 1.0× 128 0.7× 120 0.7× 229 1.5× 78 0.6× 16 717
Che‐Yuan Wu Canada 15 229 0.8× 174 0.9× 188 1.1× 44 0.3× 56 0.5× 33 655
Yi Xing China 18 212 0.7× 170 0.9× 133 0.8× 106 0.7× 50 0.4× 52 758
Ophélia Le Thuc France 11 289 1.0× 312 1.7× 144 0.9× 37 0.2× 251 2.0× 15 876
Frauke Glöckner Germany 8 157 0.6× 131 0.7× 109 0.7× 83 0.6× 81 0.7× 10 561

Countries citing papers authored by Emily B. Button

Since Specialization
Citations

This map shows the geographic impact of Emily B. Button's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily B. Button with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily B. Button more than expected).

Fields of papers citing papers by Emily B. Button

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily B. Button. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily B. Button. The network helps show where Emily B. Button may publish in the future.

Co-authorship network of co-authors of Emily B. Button

This figure shows the co-authorship network connecting the top 25 collaborators of Emily B. Button. A scholar is included among the top collaborators of Emily B. Button based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily B. Button. Emily B. Button is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zachrisson, Olof, Malin Johannesson, Linda Söderberg, et al.. (2025). Exidavnemab binds to aggregated α-synuclein in human brains affected by α-synucleinopathies. Neurotherapeutics. 23(1). e00779–e00779.
2.
Johannesson, Malin, Linda Söderberg, Olof Zachrisson, et al.. (2024). Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains. Molecular and Cellular Neuroscience. 130. 103949–103949. 20 indexed citations
3.
Söderberg, Linda, Malin Johannesson, Eleni Gkanatsiou, et al.. (2024). Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities. Scientific Reports. 14(1). 10868–10868. 22 indexed citations
4.
Button, Emily B., Wai Hang Cheng, Carlos Barrón, et al.. (2021). Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury. Alzheimer s Research & Therapy. 13(1). 58–58. 14 indexed citations
5.
Cheng, Wai Hang, Emily B. Button, Asma Bashir, et al.. (2020). ApoA-I deficiency has a subtle effect on acute inflammatory responses after experimental Traumatic Brain Injury. Open Collections. 6(1). 1 indexed citations
6.
Robert, Jérôme, Nicholas L. Weilinger, Liping Cao, et al.. (2020). An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases. Molecular Neurodegeneration. 15(1). 70–70. 11 indexed citations
7.
Robert, Jérôme, Emily B. Button, Luke McAlary, et al.. (2020). Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E. Molecular Neurodegeneration. 15(1). 23–23. 23 indexed citations
8.
Robert, Jérôme, Emily B. Button, Luke McAlary, et al.. (2020). Cerebrovascular amyloid angiopathy in bioengineered vessels is reduced by high‐density lipoprotein particles enriched in apolipoprotein E. Alzheimer s & Dementia. 16(S2). 1 indexed citations
9.
Button, Emily B., Guilaine K. Boyce, Anna Wilkinson, et al.. (2019). ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice. Alzheimer s Research & Therapy. 11(1). 44–44. 47 indexed citations
10.
Button, Emily B., Jérôme Robert, Tara M. Caffrey, et al.. (2019). HDL from an Alzheimer's disease perspective. Current Opinion in Lipidology. 30(3). 224–234. 82 indexed citations
11.
Cheng, Wai Hang, Kris M. Martens, Asma Bashir, et al.. (2019). CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice. Alzheimer s Research & Therapy. 11(1). 6–6. 47 indexed citations
12.
Bashir, Asma, Kurt A. McInnes, Emily B. Button, et al.. (2019). Increased severity of the CHIMERA model induces acute vascular injury, sub-acute deficits in memory recall, and chronic white matter gliosis. Experimental Neurology. 324. 113116–113116. 30 indexed citations
13.
Button, Emily B., et al.. (2018). Addressing Overlapping Migratory Categories within New Patterns of Mobility in Peru. Anti-Trafficking Review. 3 indexed citations
14.
Robert, Jérôme, Emily B. Button, Sophie Stukas, et al.. (2017). Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels. eLife. 6. 95 indexed citations
15.
Cheng, Wai Hang, Sophie Stukas, Kris M. Martens, et al.. (2017). Age at injury and genotype modify acute inflammatory and neurofilament-light responses to mild CHIMERA traumatic brain injury in wild-type and APP/PS1 mice. Experimental Neurology. 301(Pt A). 26–38. 33 indexed citations
16.
Robert, Jérôme, Emily B. Button, Sophie Stukas, et al.. (2017). High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture. Molecular Neurodegeneration. 12(1). 60–60. 44 indexed citations
17.
Robert, Jérôme, Sophie Stukas, Emily B. Button, et al.. (2015). Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(5). 1027–1036. 66 indexed citations
18.
Jones, Andrew, Emily B. Button, Abigail K. Rose, et al.. (2015). The ad-libitum alcohol ‘taste test’: secondary analyses of potential confounds and construct validity. Psychopharmacology. 233(5). 917–924. 46 indexed citations
19.
Bradley, Ryan M., et al.. (2015). Fasting upregulates adipose triglyceride lipase and hormone-sensitive lipase levels and phosphorylation in mouse kidney. Biochemistry and Cell Biology. 93(3). 262–267. 15 indexed citations
20.
Kazda, Christof, Oliver Bachmann, Emily B. Button, et al.. (2008). Exenatide verbessert bei Patienten mit Typ-2-Diabetes die postprandiale Glucosekontrolle, gemessen an der Konzentration von 1,5-Anhydroglucitol. Diabetologie und Stoffwechsel. 3(S 1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026